Issues
America’s housing market has been in a deep freeze for years, thanks to high borrowing costs and skyrocketing prices. But signs of hope are starting to emerge, and it’s possible a long-anticipated thaw is coming now that mortgage rates have dipped below 6%.
Could 2026 be the year of the U.S. housing turnaround? Possibly. But even if it isn’t, today we add a housing-adjacent stock that should fare well either way – especially since it’s trading at a deep discount. I see 36% upside, possibly within a matter of months. It’s a name you know well – whose products you’ve almost surely used and likely have in your garage right now.
Details inside.
Could 2026 be the year of the U.S. housing turnaround? Possibly. But even if it isn’t, today we add a housing-adjacent stock that should fare well either way – especially since it’s trading at a deep discount. I see 36% upside, possibly within a matter of months. It’s a name you know well – whose products you’ve almost surely used and likely have in your garage right now.
Details inside.
The close of the month of February, which was extremely volatile day-to-day, was another week in the red as a mix of AI-driven growth fears and geopolitical tension put pressure on broader markets. Traders sold heavily into tech and financials, keeping sentiment cautious. By week’s end, the S&P 500 had slid 0.4%, the Dow had lost 1.3%, the Nasdaq had declined by 1% and the Russell 2000 had fallen by 1.2%.
The major indexes and most stocks were hit fairly hard at the open today, though, as the day wore on the losses become minor and many stocks were actually green. Is that encouraging? You bet, especially as the big-cap indexes held support right near recent lows. That said, does it change the intermediate-term evidence at all? Not really, with the themes of the past few weeks (pockets of strength, but choppy action and some yellow flags) still with us. We’ll leave our Market Monitor at a level 6 and remain flexible.
This week’s list has something for everyone, with some cyclical plays, growth titles and a few recent breakouts. Our Top Pick is a mid-sized outfit with accelerating growth as its chips ride the AI (and other fast growing) waves.
This week’s list has something for everyone, with some cyclical plays, growth titles and a few recent breakouts. Our Top Pick is a mid-sized outfit with accelerating growth as its chips ride the AI (and other fast growing) waves.
The U.S.’s involvement in renewed conflict in the Middle East has so far done little to deter this market, despite some modest selling early Monday. That said, risk is decidedly elevated, with many growth stocks still well below their highs and the all-important VIX climbing above the 20 level today. But oil prices are on the rise too, and that means it’s a good time to capitalize in the form of a mid-cap energy play recommended by Tyler Laundon to his Cabot Early Opportunities audience last month.
Details inside.
Details inside.
The close of the month of February, which was extremely volatile day-to-day, was another week in the red as a mix of AI-driven growth fears and geopolitical tension put pressure on broader markets. Traders sold heavily into tech and financials, keeping sentiment cautious. By week’s end the S&P 500 had slid 0.4%, the Dow had lost 1.3%, the Nasdaq had declined by 1% and the Russell 2000 had fallen by 1.2%.
The close of the month of February, which was extremely volatile day-to-day, was another week in the red as a mix of AI-driven growth fears and geopolitical tension put pressure on broader markets. Traders sold heavily into tech and financials, keeping sentiment cautious. By week’s end the S&P 500 had slid 0.4%, the Dow had lost 1.3%, the Nasdaq had declined by 1% and the Russell 2000 had fallen by 1.2%.
Let’s start with some remarkable statistics.
Nvidia’s (NVDA) fourth-quarter revenue reported yesterday was $68 billion, up 73% from the same period last year. It now makes more revenue in a single quarter than most chip competitors generate in an entire year. Nvidia’s profit for the last 12 months was $120 billion. Just three years ago, Nvidia’s profit was $4.4 billion.
It is estimated that more than one-third of the value of the stock market is represented by companies based in the San Francisco Bay/Silicon Valley area.
Nvidia’s (NVDA) fourth-quarter revenue reported yesterday was $68 billion, up 73% from the same period last year. It now makes more revenue in a single quarter than most chip competitors generate in an entire year. Nvidia’s profit for the last 12 months was $120 billion. Just three years ago, Nvidia’s profit was $4.4 billion.
It is estimated that more than one-third of the value of the stock market is represented by companies based in the San Francisco Bay/Silicon Valley area.
We continue to get solid signals from the White House that cannabis rescheduling is on track. That’ll be a significant catalyst for cannabis stocks. The only question is the timing. That remains uncertain and probably unknowable. Cannabis stocks remain a buy on weakness ahead of this catalyst.
The background here is that last December, President Donald Trump signed an executive order directing the Justice Department to move cannabis to Schedule III from Schedule I under the Controlled Substances Act.
The background here is that last December, President Donald Trump signed an executive order directing the Justice Department to move cannabis to Schedule III from Schedule I under the Controlled Substances Act.
The bull market has broadened out beyond technology in a big way. While the S&P 500 is about even for the year so far, most market sectors are beating the index, and by a lot. In fact, six of the eleven sectors have a better than 8% YTD return, not even two months into the year.
The new market dynamic is having a profound impact on the portfolio. Several stocks that had been dead weight in the portfolio have soared in recent months to 52-week highs. The new market has turned previously underperforming stocks into strong income generators.
It has been a strong run for several portfolio stocks. But a largely successful earnings season is almost over. That means there will be no obvious catalyst to continue driving stocks higher, at least for now. The situation makes it a better time to capitalize on recent price surges instead of adding more positions and hoping for more.
Under the current circumstances, the biggest market opportunity right now is income. In this issue, I highlight three more high-priced covered calls on stocks that have had strong rallies.
The new market dynamic is having a profound impact on the portfolio. Several stocks that had been dead weight in the portfolio have soared in recent months to 52-week highs. The new market has turned previously underperforming stocks into strong income generators.
It has been a strong run for several portfolio stocks. But a largely successful earnings season is almost over. That means there will be no obvious catalyst to continue driving stocks higher, at least for now. The situation makes it a better time to capitalize on recent price surges instead of adding more positions and hoping for more.
Under the current circumstances, the biggest market opportunity right now is income. In this issue, I highlight three more high-priced covered calls on stocks that have had strong rallies.
In researching potential candidates for this month’s edition of the newsletter, I narrowed down my final list of top choices to the usual 10 stocks. What caught my attention when reviewing the list, however, was how many of them were in the healthcare sector—in particular, the therapeutic arena.
I was gratified by this discovery since I feel that a.) medical stocks are underrepresented in the portfolio, and b.) the sector is at once defensive in nature (always a good thing in my estimation) yet also poised to benefit from ongoing sector rotation.
I was gratified by this discovery since I feel that a.) medical stocks are underrepresented in the portfolio, and b.) the sector is at once defensive in nature (always a good thing in my estimation) yet also poised to benefit from ongoing sector rotation.
Before we dive into this week’s covered call idea, I need to address two items.
First, we are going to sell our RKT stock as the February call that we sold expired worthless, leaving us with our stock position.
First, we are going to sell our RKT stock as the February call that we sold expired worthless, leaving us with our stock position.
It remains about as mixed an environment as we can remember, which does mean the risk of some sort of convulsion (a correction, a re-rotation into laggards, etc.) is elevated. That said, as opposed to the on-again, off-again action from certain areas in January, we have seen the winners persist of late, so that’s where we’re focusing—while also holding some cash and raising stops along the way given what’s going on. For the moment, we’ll stick with a level 6 on the Market Monitor, but again, we’re OK taking swings at strong stocks.
This week’s list is very heavy on the cyclical side of things, with many names perking up and out of long ranges. Our Top Pick has a solid growth profile and has emerged on the upside after a six-month choppy phase.
This week’s list is very heavy on the cyclical side of things, with many names perking up and out of long ranges. Our Top Pick has a solid growth profile and has emerged on the upside after a six-month choppy phase.
Updates
Uncertainty in the market has soared. The situation in Iran significantly increases the near-term risk to stock prices.
The earnings catalyst has passed. Market indexes are near the high. In this environment, a very unpredictable situation in the Middle East could tip the balance. Of course, it’s impossible to know what will ultimately happen in Iran.
The earnings catalyst has passed. Market indexes are near the high. In this environment, a very unpredictable situation in the Middle East could tip the balance. Of course, it’s impossible to know what will ultimately happen in Iran.
There is a huge increase in uncertainty with the market near the high. Although stocks were mostly higher by midday on Monday, the situation in Iran adds another degree of risk.
The current situation makes this an even better time to sell covered calls on stocks near the recent high. After a huge YTD rally in several previously underperforming sectors, a few stocks are generating very high-priced call premiums. An unpredictable market with stocks near the high after the strongest rally in years is the ideal time to turn the recent market successes into high income.
The current situation makes this an even better time to sell covered calls on stocks near the recent high. After a huge YTD rally in several previously underperforming sectors, a few stocks are generating very high-priced call premiums. An unpredictable market with stocks near the high after the strongest rally in years is the ideal time to turn the recent market successes into high income.
It has been called by many pundits the biggest speculative event since the late ‘90s Internet stock mania. I’m referring, of course, to the widely referenced “AI bubble” that has been in play for the better part of the last three years.
But is it truly a “bubble” in the historical sense of the term? The answer to this question is salient for us not only as investors, generally speaking, but also as it concerns at least a couple of the stocks in our portfolio—namely Intel (INTC) and Centuri Holdings (CTRI).
But is it truly a “bubble” in the historical sense of the term? The answer to this question is salient for us not only as investors, generally speaking, but also as it concerns at least a couple of the stocks in our portfolio—namely Intel (INTC) and Centuri Holdings (CTRI).
WHAT TO DO NOW: It’s not 2008 out there, but the market environment remains very challenging, especially for growth, where most indexes, funds and stocks are struggling. That said, we have started to see some growth names emerge on the upside, and our watch list is growing—if we can see more than a day or two of strength, we’d like to put some money to work. But until then, we’re content to stay close to shore and patiently wait for growth stocks to get moving. In the Model Portfolio, we’re placing Axsome Therapeutics (AXSM) on Hold tonight; our cash position is still just above 50%.
It’s been an interesting week here in Rhode Island, where most people are finally dug out from the roughly three feet of snow that fell across the state Sunday night and into Monday.
Growing up in Vermont, major snowstorms were certainly disruptive. But more often than not, it was all about how we would get to the ski resort without going off the road.
Growing up in Vermont, major snowstorms were certainly disruptive. But more often than not, it was all about how we would get to the ski resort without going off the road.
Hello from sunny Florida!
I am on vacation with my family this week, taking a much-needed break from the harsh, snowy Vermont winter (and narrowly making it down here ahead of the latest blizzard to dump another foot or two of snow on the Northeast). But with so much going on in the market – tariffs rejected! GDP growth slowing! AI panic! – I wanted to provide an update on everything that’s going on with our stocks.
I am on vacation with my family this week, taking a much-needed break from the harsh, snowy Vermont winter (and narrowly making it down here ahead of the latest blizzard to dump another foot or two of snow on the Northeast). But with so much going on in the market – tariffs rejected! GDP growth slowing! AI panic! – I wanted to provide an update on everything that’s going on with our stocks.
It’s the same basic market story as it has been for the last four months. Technology is floundering while other sectors are killing it. But a couple of events occurring this week could potentially change the dynamic.
For value-focused investors, this year’s prologue has been a welcome change from the turmoil experienced in early 2025.
In just the past few weeks, some of last year’s most ignored or underappreciated laggards have posted outsized gains, with rallies that have made even momentum-driven tech stock traders envious. Even more remarkable is the fact that much of that strength has been concentrated in ultra-defensive areas of the market like consumer staples, utilities and healthcare.
In just the past few weeks, some of last year’s most ignored or underappreciated laggards have posted outsized gains, with rallies that have made even momentum-driven tech stock traders envious. Even more remarkable is the fact that much of that strength has been concentrated in ultra-defensive areas of the market like consumer staples, utilities and healthcare.
The market rotation continues to be the main story out there this week, though rumblings of a potential strike on Iran, an update from the January FOMC meeting, and a slew of earnings reports and economic data releases have been giving investors plenty to think about.
In terms of the rotation, the equal‑weight S&P 500 ETF (RSP) is up 5.5% so far this year, illustrating that leadership is broadening beyond the narrow group of mega‑cap stocks that drove much of last year’s performance.
Year to date, the S&P 600 SmallCap Index is up 8.3% and the S&P 400 Mid‑Cap Index is up 7.9%. Both are comfortably outperforming the S&P 500, which is up just 0.1%, and the Nasdaq, which is down 2.1%.
In terms of the rotation, the equal‑weight S&P 500 ETF (RSP) is up 5.5% so far this year, illustrating that leadership is broadening beyond the narrow group of mega‑cap stocks that drove much of last year’s performance.
Year to date, the S&P 600 SmallCap Index is up 8.3% and the S&P 400 Mid‑Cap Index is up 7.9%. Both are comfortably outperforming the S&P 500, which is up just 0.1%, and the Nasdaq, which is down 2.1%.
Happy Chinese New Year! The year of the horse is upon us.
China is expecting an incredible 9.5 billion trips to be made during the 40-day Lunar New Year travel period. Chinese automakers are also on the move as the country’s numerous brands sold nearly 200,000 vehicles in Britain last year, doubling their market share to almost 10%.
China is expecting an incredible 9.5 billion trips to be made during the 40-day Lunar New Year travel period. Chinese automakers are also on the move as the country’s numerous brands sold nearly 200,000 vehicles in Britain last year, doubling their market share to almost 10%.
As U.S. investors have shifted from risk-on to risk-off mode in recent months, a clear disparity between the “haves” and the “have-nots” has materialized.
Let’s start with the “have-nots.” Financials have fared the worst so far this year (-4.7%), followed by technology (-3.1%), communication services and consumer discretionary (-2.8% each). The downturn in the two tech-related sectors in particular is a stark departure from recent years, when technology led the charge of the current bull market.
Let’s start with the “have-nots.” Financials have fared the worst so far this year (-4.7%), followed by technology (-3.1%), communication services and consumer discretionary (-2.8% each). The downturn in the two tech-related sectors in particular is a stark departure from recent years, when technology led the charge of the current bull market.
Cyclical stocks are soaring and technology is floundering in the transformed market.
The bull market is turned upside down. For most of the first three years, technology, and particularly AI stocks, soared while most other stocks did very little. Now, previously meandering stocks are killing it while technology sinks.
The bull market is turned upside down. For most of the first three years, technology, and particularly AI stocks, soared while most other stocks did very little. Now, previously meandering stocks are killing it while technology sinks.
Alerts
SAVE was recommended by US Investment Report at $19.20 in Investment Digest issue 714, dated February 29, 2012. SAVE was removed from the USIR portfolio last week when it closed below the newsletter’s stop loss around $22....
Today we have a recommendation from the Validea Hot List that is seconded by Michael Cintolo, editor of Cabot Top Ten Trader. Validea’s methodology relies heavily on tests of essential metrics based on a specific investing style, while Cintolo’s selection process is primarily technical. The stock below scored well with both advisors.
“LKQ Corporation (LKQX) --...
“LKQ Corporation (LKQX) --...
Today’s recommendation, from Canaccord Genuity analyst Richard Davis, is a 21st-century marketing company. ExactTarget, Inc. (ET) helps companies reach potential consumers through e-mail, text messages, social networks and other interactive channels. Richard Davis explains the investment case below.
“Even adjusting for today’s fashion for conservative forecasting by analysts,ExactTarget, Inc. (ET) posted strong March quarter results. We...
“Even adjusting for today’s fashion for conservative forecasting by analysts,ExactTarget, Inc. (ET) posted strong March quarter results. We...
FRX was recommended by Validea Hot List at $34.75 in Investment Digest issue 716, dated April 4, 2012. As part of a regular portfolio rebalancing, FRX was removed from the Validea portfolio on May 11, and will no longer be tracked....
“Rogers Communications, Inc. (RCI) is being dropped from the Long-Term Buy List.
“The Canadian media conglomerate posted weak March-quarter results, and both the shares and profit estimates have declined since the release. Investors had braced for a challenging wireless environment; Canadian regulators’ decision to open the wireless market to smaller carriers...
“The Canadian media conglomerate posted weak March-quarter results, and both the shares and profit estimates have declined since the release. Investors had braced for a challenging wireless environment; Canadian regulators’ decision to open the wireless market to smaller carriers...
EMN was recommended as a buy “on dips below $48.75" in Investment Digest issue 715, dated May 14, 2012, by Personal Finance. EMN was then trading at $52.12, and has not presented a buying opportunity below $48.75 since. In this update, Personal Finance Editor Elliott Gue now recommends selling the...
Roy Ward, editor of Cabot Benjamin Graham Value Letter, recommends stocks based on his own thorough analysis of their valuation. While he normally considers a range of factors to determine the levels at which a stock would be over- or under-valued, a recent special issue focused exclusively on stocks that are...
MELI was recommended by Cabot China & Emerging Markets Report at $69.20 inInvestment Digest issue 677, dated August 18, 2010.
“Earnings season remains a minefield, and the unsettled state of the market only increases the potential downside for companies that fail to meet analysts’ expectations. That’s just what happened to MercadoLibre, Inc. (MELI), the ‘eBay...
“Earnings season remains a minefield, and the unsettled state of the market only increases the potential downside for companies that fail to meet analysts’ expectations. That’s just what happened to MercadoLibre, Inc. (MELI), the ‘eBay...
“Patterson Companies, Inc. (PDCO), a member of the subgroup ‘Medical Supplies,’ outperformed yesterday with a gain of 1%. The longer-term P&F relative chart shows steady performance with some strength this month.
“The price chart holds its primary uptrend off the 2009 March low. The trend has not been dented by the...
“The price chart holds its primary uptrend off the 2009 March low. The trend has not been dented by the...
MDF was recommended by Upside at $5.45 in Investment Digest issue 700, dated August 3, 2011.
“Metropolitan Health Networks’ (MDF) March-quarter earnings per share were $0.19, flat from a year earlier and a penny below the two-analyst consensus. Sales more than doubled to $195 million, partly reflecting the acquisition of Continucare in 2011. The company, a...
“Metropolitan Health Networks’ (MDF) March-quarter earnings per share were $0.19, flat from a year earlier and a penny below the two-analyst consensus. Sales more than doubled to $195 million, partly reflecting the acquisition of Continucare in 2011. The company, a...
“There are two seasonal short trades that typically begin in June. Banking and Natural Gas have a seasonal tendency to peak in the second month of the ‘Worst Six Months.’ Seasonal weakness has proven to be consistent over the past five-, 10- and 15-year time periods, with average declines ranging...
YNDX was recommended at $23.92 by Cabot Stock of the Month in the latest Investment Digest, issue 718, dated May 2, 2012. YNDX closed yesterday at $21.82.
“Yandex NV (YNDX), a recommendation of Cabot China & Emerging Markets Report, was recommended two weeks ago at what had a good chance to be a low-risk entry...
“Yandex NV (YNDX), a recommendation of Cabot China & Emerging Markets Report, was recommended two weeks ago at what had a good chance to be a low-risk entry...
Portfolios
Strategy
Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.